PainReform Ltd PRFX.OQ PRFX.O is expected to report resultson March 17 (estimated) for the period ending September 30 2024
LSEG's mean analyst estimate for PainReform Ltd is for a loss of $18.96 per share.
The one available analyst rating on the shares is "hold".
The mean earnings estimate of analysts was unchanged in the last three months.
This summary was machine generated March 14 at 11:03 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)